Transition Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$13.3M
- Investors
-
6
Transition Bio General Information
Description
Operator of a biotechnology company intended to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. The company harnesses droplet microfluidic approaches and protein biophysics platforms to characterize condensates with unprecedented precision, enabling medical practitioners to map condensates in molecular detail.
Contact Information
Website
www.transitionbio.comCorporate Office
- 1 Mifflin Place
- Suite 400
- Cambridge, MA 02138
- United States
Corporate Office
- 1 Mifflin Place
- Suite 400
- Cambridge, MA 02138
- United States
Transition Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 24-Oct-2024 | $13.3M | Completed | Clinical Trials - General | ||
| 4. Early Stage VC | Completed | Clinical Trials - General | ||||
| 3. Early Stage VC (Series A) | 02-Jun-2022 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 01-Sep-2020 | $9M | $9M | Completed | Startup | |
| 1. University Spin-Out | 16-Jul-2020 | Completed | Startup |
Transition Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Transition Bio Comparisons
Industry
Financing
Details
Transition Bio Competitors (2)
One of Transition Bio’s 2 competitors is Owkin, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Owkin | Venture Capital-Backed | Paris, France | ||||
| Numerion Labs | Venture Capital-Backed | San Francisco, CA |
Transition Bio Patents
Transition Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202318929-D0 | New compounds and methods | Inactive | 12-Dec-2023 | ||
| EP-4805092-A1 | New compounds and methods | Pending | 08-Nov-2023 | ||
| WO-2025099451-A1 | New compounds and methods | Inactive | 08-Nov-2023 | ||
| EP-4771389-A1 | High-throughput condensate modulator screen | Pending | 01-Sep-2023 | ||
| WO-2025050003-A1 | High-throughput condensate modulator screen | Inactive | 01-Sep-2023 | C40B30/10 |
Transition Bio Signals
Transition Bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Minority | ||
| Magnetic Ventures | Venture Capital | Minority | ||
| Northpond Ventures | Venture Capital | Minority | ||
| Taiho Ventures | Corporate Venture Capital | Minority | ||
| Lifeforce Capital | Venture Capital | Minority |
Transition Bio FAQs
-
When was Transition Bio founded?
Transition Bio was founded in 2020.
-
Where is Transition Bio headquartered?
Transition Bio is headquartered in Cambridge, MA.
-
What is the size of Transition Bio?
Transition Bio has 27 total employees.
-
What industry is Transition Bio in?
Transition Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Transition Bio a private or public company?
Transition Bio is a Private company.
-
What is the current valuation of Transition Bio?
The current valuation of Transition Bio is .
-
What is Transition Bio’s current revenue?
The current revenue for Transition Bio is .
-
How much funding has Transition Bio raised over time?
Transition Bio has raised $76.5M.
-
Who are Transition Bio’s investors?
Bristol-Myers Squibb, Magnetic Ventures, Northpond Ventures, Taiho Ventures, and Lifeforce Capital are 5 of 6 investors who have invested in Transition Bio.
-
Who are Transition Bio’s competitors?
Owkin and Numerion Labs are competitors of Transition Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process